Neurogenex Co., Ltd.

Republic of Korea

Back to Profile

1-2 of 2 for Neurogenex Co., Ltd. Sort by
Query
Aggregations
IPC Class
A23L 1/29 - Modifying nutritive qualities of foods; Dietetic products ( A23L 1/09 takes precedence;dietetic salt substitutes A23L 1/22) 1
A61K 36/23 - Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin 1
A61K 36/39 - Convolvulaceae (Morning-glory family), e.g. bindweed 1
A61K 36/47 - Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean) 1
A61K 36/714 - Aconitum (monkshood) 1
See more
Found results for  patents

1.

MEDICINAL PLANT EXTRACTS ACTING AS BETA2 AGONIST FOR ASTHMA TREATMENT

      
Application Number KR2007000523
Publication Number 2008/093902
Status In Force
Filing Date 2007-01-31
Publication Date 2008-08-07
Owner NEUROGENEX CO., LTD. (Republic of Korea)
Inventor
  • Choi, Eun-Wook
  • Lee, Dong-Seok
  • Lee, Tae-Gyu
  • Seen, Dong-Seung
  • Park, Sang-Wook
  • Choi, Eun-Jung

Abstract

The present invention relates to medicinal plant extracts acting as β2 receptor agonist. More specifically, this invention relates to extracts from one or more medicinal plants or parts of the plants, such as Euphorbiae kansui, Anthriscus sylvestris, Croton Tiglium, Aconitum carmichaeli, Daphne genkwa, Calystegia soldanellan and Sapium japonicum, wherein the extracts enhance β2 receptor activity and relieve airway contraction of an asthmatic patient. This invention also relates to a method of extracting medicinal plant constituents more efficiently, and relates to raw materials, functional foods or natural product medicines, which contain the medicinal plant extracts, for preventing and treating asthma.

IPC Classes  ?

  • A61K 36/47 - Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
  • A61K 36/23 - Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
  • A61K 36/714 - Aconitum (monkshood)
  • A61K 36/83 - Thymelaeaceae (Mezereum family), e.g. leatherwood or false ohelo
  • A61K 36/39 - Convolvulaceae (Morning-glory family), e.g. bindweed
  • A23L 1/29 - Modifying nutritive qualities of foods; Dietetic products ( A23L 1/09 takes precedence;dietetic salt substitutes A23L 1/22)
  • A61P 11/06 - Antiasthmatics
  • A61P 11/08 - Bronchodilators

2.

USE OF THE GONADOTROPIN-RELEASING HORMONE II ANTAGONISTS AND ITS ANALOGUES

      
Application Number KR2005003667
Publication Number 2007/052854
Status In Force
Filing Date 2005-11-02
Publication Date 2007-05-10
Owner NEUROGENEX CO., LTD. (Republic of Korea)
Inventor
  • Seong, Jae-Young
  • Cheon, Jun
  • Seen, Dong-Seung

Abstract

This invention relates to a gonadotropin-releasing hormone-2 (GnRH-2) antagonist, trptorelix-1 and its analogues. In accordance with the present invention, the trptorelix-1 and its analogues induce apoptosis of a prostate cancer cell. Therefore, the trptorelix-1 and its analogues can be used to treat prostate cancer.

IPC Classes  ?

  • C07K 7/06 - Linear peptides containing only normal peptide links having 5 to 11 amino acids
  • A61K 38/02 - Peptides of undefined number of amino acidsDerivatives thereof
  • A61K 38/08 - Peptides having 5 to 11 amino acids